Madrigal Pharmaceuticals, Inc.
- MDGL
- NASDAQ
- Biotechnology
- Liver Disease (NASH)
- Cardiometabolic Drugs
$449.74
Today −2.19%Quote Oct 16, 2026, 08:00 PM UTC
−15.84%over the last month
Max drawdown −15.8%From 1-month high −15.8%3 months −16.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$10.39B
Quote Oct 16
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$686.44
+52.6% from here
Floor
$443.58
1.4% below price
Where the price sits
25 analysts
Analyst range, low to high
$542.00$962.00
- Price $449.74
- Resistance $456.87
- Consensus $686.44
The price is just above its floor and right under resistance. Analysts' average target sits about 53% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MDGLPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
915